Prostate Cancer Clinical Trials

Ongoing Prostate Cancer Trials @ NCIS - Patient Recruitment

Protocol Title Principal Investigator Status
Primary prostate cancer imaging with PET/MRI and PET/CT with focus on localisation and grading 


A/Prof Edmund Chiong


9785-CL-0403A- Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to evaluate the risk of seizure among subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with Enzalutamide who are at potential increased risk of seizure



A/Prof Edmund Chiong


Recruitment completed

PROSPER: A multi-national, Phase 3, Randomised, Double‑Blind, Placebo‑Controlled, Efficacy and Safety Study of Enzalutamide in patients with Nonmetastatic Castration‑Resistant Prostate Cancer

A/Prof Edmund Chiong


A multi-national Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV 3100 in Chemotherapy-Naïve Patients with Progressive Metastatic Prostate Cancer who have Failed Androgen Deprivation Therapy

A/Prof Edmund Chiong Recruitment completed

A prospective, longitudinal, multi-national, observational study to describe patterns of care and outcomes of Men who are at High Risk for Poor Clinical Outcomes after Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men with Metastatic Prostate Cancer at Initial Diagnosis.


A/Prof Edmund Chiong Ongoing

A prospective randomised pilot study evaluating the food effect on the pharmacokinetics and pharmacodynamics of abiraterone acetate in men with castrate resistant prostate cancer

Dr Yong Wei Peng Completed


For more information or to enroll in the Prostate Cancer clinical trials, please contact Dr Lata Raman at